REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 27th, 2008 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledMarch 27th, 2008 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) is made and entered into as of October 25, 2007, among XTL Biopharmaceuticals Ltd., a public company limited by shares organized under the laws of the State of Israel (the “Company”), and the purchasers’ signatory hereto (each such purchaser is a “Purchaser” and all such purchasers are, collectively, the “Purchasers”).
LICENSE AGREEMENT By and Between PRESIDIO PHARMACEUTICALS, INC. and XTL BIOPHARMACEUTICALS LTD.License Agreement • March 27th, 2008 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledMarch 27th, 2008 Company Industry JurisdictionThis License Agreement (this “Agreement”), dated the 19th day of March, 2008 (the “Effective Date”), is by and between Presidio Pharmaceuticals, Inc., a Delaware corporation (“PRESIDIO”), and XTL Biopharmaceuticals Ltd., a public company limited by shares organized under the laws of Israel (“XTL”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2008 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledMarch 27th, 2008 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 17, 2006, among XTL Biopharmaceuticals Ltd., a public company limited by shares organized under the laws of the State of Israel (the “Company”), and the purchasers identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”); and
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2008 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledMarch 27th, 2008 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 25, 2007 among XTL Biopharmaceuticals Ltd., a public company limited by shares organized under the laws of the State of Israel (the “Company”), and the purchasers identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”); and